Rossella.Fioravanti@uniroma1.it's picture

gli studenti si ricevono tutti i giorni previo appuntamento via mail

Course Code Year Course - Attendance
Complements of medicinal and toxicological chemistry 1045024 2021/2022 Pharmacy
ANALYSIS OF DRUGS WITH LABORATORY II 1026160 2021/2022 Pharmacy
PHARMACEUTICAL CHEMISTRY AND PHARMACEUTICAL TECHNOLOGIES 1023914 2021/2022 Biotechnologies
Complements of medicinal and toxicological chemistry 1045024 2020/2021 Pharmacy
ANALYSIS OF DRUGS WITH LABORATORY II 1026160 2020/2021 Pharmacy
PHARMACEUTICAL CHEMISTRY AND PHARMACEUTICAL TECHNOLOGIES 1023914 2020/2021 Biotechnologies
ANALYSIS OF DRUGS WITH LABORATORY II 1026160 2019/2020 Pharmacy
Complements of medicinal and toxicological chemistry 1045024 2019/2020 Pharmacy
PHARMACEUTICAL CHEMISTRY AND PHARMACEUTICAL TECHNOLOGIES 1023914 2019/2020 Biotechnologies
ANALYSIS OF DRUGS WITH LABORATORY II 1026160 2018/2019 Pharmacy
Complements of medicinal and toxicological chemistry 1045024 2018/2019 Pharmacy
ANALYSIS OF ACTIVE SUBSTANCES IN MEDICINAL AND AROMATIC PLANTS 1022988 2017/2018 Applied Pharmaceutical Sciences
ANALYSIS OF DRUGS WITH LABORATORY II 1026160 2017/2018 Pharmacy
Complements of medicinal and toxicological chemistry 1045024 2017/2018 Pharmacy
PHARMACEUTICAL CHEMISTRY AND PHARMACEUTICAL TECHNOLOGIES 1023914 2017/2018 Biotechnologies
ANALYSIS OF ACTIVE SUBSTANCES IN MEDICINAL AND AROMATIC PLANTS 1022988 2016/2017 Applied Pharmaceutical Sciences
ANALYSIS OF DRUGS WITH LABORATORY II 1026160 2016/2017 Pharmacy
Complements of medicinal and toxicological chemistry 1045024 2016/2017 Pharmacy
PHARMACEUTICAL CHEMISTRY AND PHARMACEUTICAL TECHNOLOGIES 1023914 2016/2017 Biotechnologies
Title Journal Year
Novel quinoline compounds active in cancer cells through coupled DNA methyltransferase inhibition and degradation CANCERS 2020
Tranylcypromine-based LSD1 inhibitors: structure-activity relationships, antiproliferative effects in leukemia, and gene target modulation CHEMMEDCHEM 2020
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation SCIENCE ADVANCES 2020
Design of first-in-class dual EZH2/HDAC inhibitor: biochemical activity and biological evaluation in cancer cells ACS MEDICINAL CHEMISTRY LETTERS 2020
Targeting histone acetylation/deacetylation in parasites: an update (2017–2020) CURRENT OPINION IN CHEMICAL BIOLOGY 2020
Properly substituted cyclic Bis-(2-bromobenzylidene) compounds behaved as dual p300/CARM1 Inhibitors and Induced apoptosis in cancer cells MOLECULES 2020
CDK9 as a valuable target in cancer: from natural compounds inhibitors to current treatment in pediatric soft tissue sarcomas FRONTIERS IN PHARMACOLOGY 2020
Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity CHEMMEDCHEM 2020
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells CLINICAL EPIGENETICS 2019
design, synthesis, antiviral evaluation, and SAR studies of new 1-(phenylsulfonyl)-1H-pyrazol-4-yl-methylaniline derivatives FRONTIERS IN CHEMISTRY 2019
Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype CLINICAL EPIGENETICS 2019
Histone deacetylases contribute to excitotoxicity-triggered degeneration of retinal ganglion cells in vivo MOLECULAR NEUROBIOLOGY 2019
Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer CURRENT OPINION IN CHEMICAL BIOLOGY 2019
Six years (2012-2018) of researches on catalytic EZH2 inhibitors: the boom of the 2-pyridone compounds THE CHEMICAL RECORD 2018
Inhibitors of yellow fever virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: design, synthesis and antiviral evaluation EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2017
(E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2016
3-(Phenyl-4-oxy)-5-phenyl-4,5-dihydro-(1H)-pyrazole: a fascinating molecular framework to study the enantioseparation ability of the amylose (3,5-dimethylphenylcarbamate) chiral stationary phase. Part I. Structure-enantioselectivity relationships JOURNAL OF CHROMATOGRAPHY A 2016
N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)anilines: a novel class of anti-RSV agents BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2015
Department
CHIMICA E TECNOLOGIE DEL FARMACO
SSD

CHIM/08